{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:38:00Z","timestamp":1792132680751,"version":"4.4.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT24847"],"award-info":[{"award-number":["IT24847"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT27497"],"award-info":[{"award-number":["IT27497"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.celrep.2023.112203","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T17:21:58Z","timestamp":1678123318000},"page":"112203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["A non-hallucinogenic LSD analog with therapeutic potential for mood disorders"],"prefix":"10.1016","volume":"42","author":[{"given":"Vern","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Bonniwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janelle K.","family":"Lanham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdi","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooshmand","family":"Sheshbaradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie M.","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Alberto","family":"Bautista-Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Arsenault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Telfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimeh-Frouh","family":"Taghavi-Abkuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatema","family":"El Sayegh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Abizaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Halberstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argel","family":"Aguilar-Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-9413","authenticated-orcid":false,"given":"John D.","family":"McCorvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112203_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1017\/S2045796015000189","article-title":"Anxious and non-anxious major depressive disorder in the World Health Organization World Mental Health Surveys","volume":"24","author":"Kessler","year":"2015","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.celrep.2023.112203_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1176\/appi.ajp.2020.20030305","article-title":"The critical relationship between anxiety and depression","volume":"177","author":"Kalin","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.euroneuro.2007.05.004","article-title":"Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target","volume":"17","author":"Lader","year":"2007","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.celrep.2023.112203_bib4","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10300.1","article-title":"Recent advances in predicting responses to antidepressant treatment","volume":"6","author":"Frodl","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.celrep.2023.112203_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1021\/acschemneuro.9b00493","article-title":"Psychedelics, but not ketamine, produce persistent antidepressant-like effects in a rodent experimental system for the study of depression","volume":"11","author":"Hibicke","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.724606","article-title":"Psychedelics and neuroplasticity: a systematic review unraveling the biological underpinnings of psychedelics","volume":"12","author":"de Vos","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.celrep.2023.112203_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.celrep.2023.112203_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years","volume":"6","author":"Dos Santos","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.celrep.2023.112203_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s43440-020-00097-z","article-title":"Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials","volume":"72","author":"Kryst","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.celrep.2023.112203_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1523\/JNEUROSCI.1659-20.2020","article-title":"Hallucinogens in mental Health: preclinical and clinical studies on LSD, psilocybin, MDMA, and ketamine","volume":"41","author":"De Gregorio","year":"2021","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jpsychires.2022.04.035","article-title":"The abuse liability of ketamine: a scoping review of preclinical and clinical studies","volume":"151","author":"Le","year":"2022","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.celrep.2023.112203_bib15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib16","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpsychires.2021.05.019","article-title":"Registered clinical studies investigating psychedelic drugs for psychiatric disorders","volume":"139","author":"Siegel","year":"2021","journal-title":"J.\u00a0Psychiatr. Res."},{"key":"10.1016\/j.celrep.2023.112203_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1021\/acsptsci.0c00192","article-title":"The subjective effects of psychedelics may not be necessary for their enduring therapeutic effects","volume":"4","author":"Olson","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.celrep.2023.112203_bib19","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1021\/acsptsci.0c00194","article-title":"The subjective effects of psychedelics are necessary for their enduring therapeutic effects","volume":"4","author":"Yaden","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.celrep.2023.112203_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0269881120959609","article-title":"Brain serotonin 2A receptor binding predicts subjective temporal and mystical effects of psilocybin in healthy humans","volume":"35","author":"Stenb\u00e6k","year":"2021","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2022489118","article-title":"Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice","volume":"118","author":"Hesselgrave","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112203_bib23","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41380-019-0615-x","article-title":"Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model","volume":"25","author":"Price","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","article-title":"Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth","volume":"4","author":"Ly","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.celrep.2023.112203_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2023.112203_bib26","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3892\/etm.2021.10565","article-title":"Neuroplasticity and depression: Rewiring the brain's networks through pharmacological therapy (Review)","volume":"22","author":"R\u0103dulescu","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.celrep.2023.112203_bib27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41586-020-3008-z","article-title":"A non-hallucinogenic psychedelic analogue with therapeutic potential","volume":"589","author":"Cameron","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112203_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hlca.19430260326","article-title":"Partialsynthese von Alkaloiden vom Typus des Ergobasins. (6. Mitteilung \u00fcber Mutterkornalkaloide)","volume":"26","author":"Stoll","year":"1943","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.celrep.2023.112203_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.15288\/qjsa.1959.20.292","article-title":"Some reflections on the possible therapeutic effects of the hallucinogens; with special reference to alcoholism","volume":"20","author":"Smith","year":"1959","journal-title":"Q.\u00a0J. Stud. Alcohol"},{"key":"10.1016\/j.celrep.2023.112203_bib30","first-page":"218","article-title":"Cholinesterase, dlysergic acid diethylamide, and 2-bromolysergic acid diethylamide","volume":"20","author":"Bertino","year":"1959","journal-title":"J.\u00a0Clin. Exp. Psychopathol. Q. Rev. Psychiatry Neurol."},{"key":"10.1016\/j.celrep.2023.112203_bib31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1177\/0333102410363490","article-title":"The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: an open, non-randomized case series","volume":"30","author":"Karst","year":"2010","journal-title":"Cephalalgia"},{"key":"10.1016\/j.celrep.2023.112203_bib32","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","article-title":"Response of cluster headache to psilocybin and LSD","volume":"66","author":"Sewell","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.celrep.2023.112203_bib33","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0026-895X(25)09168-0","article-title":"Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide","volume":"42","author":"Burris","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/178210a0","article-title":"Prevention of psychological effects of d-lysergic acid diethylamide (LSD 25) by its 2-brom derivative (BOL 148)","volume":"178","author":"Ginzel","year":"1956","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112203_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.cell.2018.01.001","article-title":"5-HT(2C) receptor structures reveal the structural Basis of GPCR polypharmacology","volume":"172","author":"Peng","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112203_bib36","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112203_bib37","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0022-3565(24)36476-6","article-title":"High-affinity agonist binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2A receptors: evidence in favor of a modified ternary complex model","volume":"280","author":"Roth","year":"1997","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2023.112203_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41589-020-0535-8","article-title":"TRUPATH, an open-source biosensor platform for interrogating the GPCR transducerome","volume":"16","author":"Olsen","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2023.112203_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-Bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112203_bib40","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1517\/14656566.2013.806487","article-title":"Activation of 5-hydroxytryptamine1B\/1D\/1F receptors as a mechanism of action of antimigraine drugs","volume":"14","author":"Ram\u00edrez Rosas","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.celrep.2023.112203_bib41","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/acschemneuro.1c00061","article-title":"2-Phenyl-1H-pyrrole-3-carboxamide as a new scaffold for developing 5-HT(6) receptor inverse agonists with cognition-enhancing activity","volume":"12","author":"Drop","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF02245940","article-title":"LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors","volume":"118","author":"Watts","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib43","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.celrep.2023.112203_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bcp.2005.11.007","article-title":"Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms","volume":"71","author":"Zhang","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s002130050125","article-title":"Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions","volume":"128","author":"Dursun","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib47","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/dta.1333","article-title":"Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model","volume":"4","author":"Canal","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.celrep.2023.112203_bib48","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2023.112203_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0306-4522(91)90128-B","article-title":"5-Hydroxytryptamine2 and 5-hydroxytryptamine 1A receptors mediate opposing responses on membrane excitability in rat association cortex","volume":"40","author":"Araneda","year":"1991","journal-title":"Neuroscience"},{"key":"10.1016\/j.celrep.2023.112203_bib50","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1021\/acsomega.7b00629","article-title":"Existence of brain 5-HT1A-5-HT2A isoreceptor complexes with antagonistic allosteric receptor-receptor interactions regulating 5-HT1A receptor recognition","volume":"2","author":"Borroto-Escuela","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.celrep.2023.112203_bib51","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0091-3057(90)90098-3","article-title":"Do functional relationships exist between 5-HT1A and 5-HT2 receptors?","volume":"36","author":"Darmani","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.celrep.2023.112203_bib52","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-3565(25)09485-6","article-title":"(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A\/2C antagonists, D1 antagonists and 5-HT1A agonists","volume":"273","author":"Schreiber","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2023.112203_bib53","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/dta.2222","article-title":"Return of the lysergamides. Part IV: analytical and pharmacological characterization of lysergic acid morpholide (LSM-775)","volume":"10","author":"Brandt","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.celrep.2023.112203_bib54","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1517\/14740330902931524","article-title":"Serotonergic drugs and valvular heart disease","volume":"8","author":"Rothman","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.celrep.2023.112203_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.celrep.2023.112203_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pharmthera.2011.03.008","article-title":"Serotonin receptors and heart valve disease--it was meant 2B","volume":"132","author":"Hutcheson","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.celrep.2023.112203_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.pharmtox.010909.105800","article-title":"Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors","volume":"52","author":"Reiter","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.celrep.2023.112203_bib58","doi-asserted-by":"crossref","first-page":"9841","DOI":"10.1021\/acs.jmedchem.8b00435","article-title":"Biased ligands of G protein-coupled receptors (GPCRs): Structure-functional selectivity relationships (SFSRs) and therapeutic potential","volume":"61","author":"Tan","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.celrep.2023.112203_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-03047-0","article-title":"Antidepressant actions of ketamine engage cell-specific translation via eIF4E","volume":"590","author":"Aguilar-Valles","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112203_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat8078","article-title":"Sustained rescue of prefrontal circuit dysfunction by antidepressant-induced spine formation","volume":"364","author":"Moda-Sava","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112203_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatr."},{"key":"10.1016\/j.celrep.2023.112203_bib62","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1177\/0269881114531666","article-title":"Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling","volume":"28","author":"Buchborn","year":"2014","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib63","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib64","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/acschemneuro.8b00134","article-title":"Effects of N, N-dimethyltryptamine on rat behaviors relevant to anxiety and depression","volume":"9","author":"Cameron","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00441-018-2973-0","article-title":"Animal models of depression: pros and cons","volume":"377","author":"Harro","year":"2019","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.celrep.2023.112203_bib66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00213-021-05982-w","article-title":"Chronic mild stress paradigm as a rat model of depression: facts, artifacts, and future perspectives","volume":"239","author":"Strekalova","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib67","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112203_bib68","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mp.2015.176","article-title":"Activation of a ventral hippocampus-medial prefrontal cortex pathway is both necessary and sufficient for an antidepressant response to ketamine","volume":"21","author":"Carreno","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib69","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1172\/JCI130808","article-title":"GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions","volume":"130","author":"Gerhard","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.celrep.2023.112203_bib70","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1038\/s41380-020-00916-y","article-title":"Inhibition of GABA interneurons in the mPFC is sufficient and necessary for rapid antidepressant responses","volume":"26","author":"Foga\u00e7a","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib71","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature11617","article-title":"A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge","volume":"492","author":"Warden","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112203_bib72","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/s41467-018-04883-5","article-title":"Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E","volume":"9","author":"Aguilar-Valles","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112203_bib73","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/oxfordjournals.bmb.a011570","article-title":"The neuroendocrinology of depression and chronic stress","volume":"52","author":"Checkley","year":"1996","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.celrep.2023.112203_bib74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yfrne.2018.02.001","article-title":"The effects of chronic stress on the human brain: from neurotoxicity, to vulnerability, to opportunity","volume":"49","author":"Lupien","year":"2018","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.celrep.2023.112203_bib75","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neubiorev.2017.08.019","article-title":"Treatment resistant depression: a multi-scale, systems biology approach","volume":"84","author":"Akil","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.celrep.2023.112203_bib76","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.biopsych.2019.04.011","article-title":"Neurobiology of resilience: Interface between mind and body","volume":"86","author":"Cathomas","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib77","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/pharmrev.120.000056","article-title":"Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms","volume":"73","author":"Inserra","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.celrep.2023.112203_bib78","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41386-022-01301-9","article-title":"Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline","volume":"47","author":"De Gregorio","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib79","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41386-018-0105-x","article-title":"Profiling changes in cortical astroglial cells following chronic stress","volume":"43","author":"Simard","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib80","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00702-019-02084-y","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"Planchez","year":"2019","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.celrep.2023.112203_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib82","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib83","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/acsptsci.0c00176","article-title":"Investigation of the structure-activity relationships of psilocybin analogues","volume":"4","author":"Klein","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.celrep.2023.112203_bib84","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-3057(01)00552-4","article-title":"Modulation of 5-HT(2A) receptor-mediated head-twitch behaviour in the rat by 5-HT(2C) receptor agonists","volume":"69","author":"Vickers","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.celrep.2023.112203_bib85","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00409110","article-title":"Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25)","volume":"1","author":"Isbell","year":"1959","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.celrep.2023.112203_bib86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00408108","article-title":"Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)","volume":"1","author":"Isbell","year":"1959","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.celrep.2023.112203_bib87","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.CIR.16.4.523","article-title":"Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors","volume":"16","author":"Schneckloth","year":"1957","journal-title":"Circulation"},{"key":"10.1016\/j.celrep.2023.112203_bib88","first-page":"137","article-title":"Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain","volume":"3","author":"Buckholtz","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-2999(85)90407-8","article-title":"Daily LSD administration selectively decreases serotonin2 receptor binding in rat brain","volume":"109","author":"Buckholtz","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib90","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s002130051000","article-title":"Mechanism of tolerance development to 2,5-dimethoxy-4-iodoamphetamine in rats: down-regulation of the 5-HT2A, but not 5-HT2C, receptor","volume":"144","author":"Smith","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.celrep.2023.112203_bib91","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1038\/sj.npp.1300711","article-title":"Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex","volume":"30","author":"Gresch","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.celrep.2023.112203_bib92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00407974","article-title":"Cross tolerance between LSD and psilocybin","volume":"2","author":"Isbell","year":"1961","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.celrep.2023.112203_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00413101","article-title":"Cross tolerance between mescaline and LSD-25, with a comparison of the mescaline and LSD reactions","volume":"3","author":"Wolbach","year":"1962","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.celrep.2023.112203_bib94","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1046\/j.1471-4159.1999.0722206.x","article-title":"Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins","volume":"72","author":"Gelber","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.celrep.2023.112203_bib95","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1021\/acschemneuro.2c00170","article-title":"Tolerance and cross-tolerance among psychedelic and nonpsychedelic 5-HT(2A) receptor agonists in mice","volume":"13","author":"de la Fuente Revenga","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib96","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.celrep.2023.112203_bib97","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of beta-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.celrep.2023.112203_bib98","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62552","article-title":"ss-arrestin 2 germline knockout does not attenuate opioid respiratory depression","volume":"10","author":"Bachmutsky","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112203_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000356423","article-title":"Stress, memory, and the hippocampus","volume":"34","author":"Wingenfeld","year":"2014","journal-title":"Front. Neurol. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib101","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2023.112203_bib102","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41398-020-01011-0","article-title":"N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in\u00a0vitro and in\u00a0vivo","volume":"10","author":"Morales-Garcia","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.celrep.2023.112203_bib103","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.ceb.2011.09.002","article-title":"Cell atrophy and loss in depression: reversal by antidepressant treatment","volume":"23","author":"Banasr","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.celrep.2023.112203_bib104","first-page":"1","article-title":"Time to abolish the forced swim test in rats for depression research?","volume":"4","author":"Carvalho","year":"2021","journal-title":"J.\u00a0Appl. Anim. Ethics Res."},{"key":"10.1016\/j.celrep.2023.112203_bib105","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acschemneuro.7b00042","article-title":"The rodent forced swim test measures stress-coping strategy, not depression-like behavior","volume":"8","author":"Commons","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2017.11.003","article-title":"Revisiting the validity of the mouse forced swim test: systematic review and meta-analysis of the effects of prototypic antidepressants","volume":"84","author":"Kara","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.celrep.2023.112203_bib107","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ynstr.2016.08.002","article-title":"The chronic mild stress (CMS) model of depression: history, evaluation and usage","volume":"6","author":"Willner","year":"2017","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.celrep.2023.112203_bib108","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2023.112203_bib109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(02)00166-1","article-title":"The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations","volume":"46","author":"Cheng","year":"2001","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.celrep.2023.112203_bib110","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1038\/s41598-020-65264-x","article-title":"Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network","volume":"10","author":"Halberstadt","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2023.112203_bib111","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","article-title":"DeepLabCut: markerless pose estimation of user-defined body parts with deep learning","volume":"21","author":"Mathis","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2023.112203_bib112","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/s41596-019-0176-0","article-title":"Using DeepLabCut for 3D markerless pose estimation across species and behaviors","volume":"14","author":"Nath","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2023.112203_bib113","series-title":"Deep Residual Learning for\u00a0Image Recognition","first-page":"770","author":"He","year":"2016"},{"key":"10.1016\/j.celrep.2023.112203_bib114","article-title":"DeeperCut: a deeper, stronger, and faster multi-person pose estimation model","author":"Insafutdinov","year":"2016","journal-title":"arXiv"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723002140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723002140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T12:03:26Z","timestamp":1761912206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723002140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2211124723002140"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112203","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A non-hallucinogenic LSD analog with therapeutic potential for mood disorders","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"112203"}}